Dificid Related Published Studies
Well-designed clinical trials related to Dificid (Fidaxomicin)
Resolution of Clostridium difficile-associated diarrhea in patients with cancer
treated with fidaxomicin or vancomycin. [2013]
Fidaxomicin preserves the intestinal microbiome during and after treatment of
Clostridium difficile infection (CDI) and reduces both toxin reexpression and
recurrence of CDI. [2012]
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and
Candida species in patients treated with fidaxomicin versus vancomycin for
Clostridium difficile infection. [2012]
Fidaxomicin attains high fecal concentrations with minimal plasma concentrations
following oral administration in patients with Clostridium difficile infection. [2012]
Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile
infection. [2010]
Well-designed clinical trials possibly related to Dificid (Fidaxomicin)
Effect of age on treatment outcomes in Clostridium difficile infection. [2013]
Decreased cure and increased recurrence rates for Clostridium difficile infection
caused by the epidemic C. difficile BI strain. [2012]
Other research related to Dificid (Fidaxomicin)
Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow
spectrum antibiotic. [2013]
Relapse versus reinfection: recurrent Clostridium difficile infection following
treatment with fidaxomicin or vancomycin. [2012]
Fidaxomicin for Clostridium difficile-associated diarrhoea: epidemiological
method for estimation of warranted price. [2012]
Efficacy and safety of fidaxomicin compared with oral vancomycin for the
treatment of adults with Clostridium difficile-associated diarrhea: data from the
OPT-80-003 and OPT-80-004 studies. [2012]
Fidaxomicin: first-in-class macrocyclic antibiotic. [2011]
Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80)
phase II study for C. difficile infection. [2009]
Other possibly related research studies
[Challenges of Clostridium difficile infection]. [Article in German] [2013]
New developments in chemotherapeutic options for Clostridium difficile colitis. [2013]
Renal impairment and clinical outcomes of Clostridium difficile infection in two
randomized trials. [2013]
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. [2011]
Emerging therapies for Clostridium difficile infections. [2011]
Clostridium difficile infection: update on emerging antibiotic treatment options
and antibiotic resistance. [2010]
|